Tirzepatide for Binge Eating Disorder
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests if tirzepatide (a weekly injection) can help reduce binge eating compared to a placebo or another medication (lisdexamfetamine dimesylate). It may be a good fit for people with moderate or severe binge eating disorder who also have a high body weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have binge eating disorder with at least 4 binge episodes per week.
- Your body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related health problem like high blood pressure.
- You have tried to lose weight with dieting before but it hasn't worked.
- You are willing to learn to give yourself a weekly injection and take daily capsules.
- You do not have diabetes, bulimia, anorexia, or certain other medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This trial tests whether a weekly injection called tirzepatide (a diabetes and weight-loss medication) can help people with obesity and stimulant use disorder reduce stimulant use and lose weight. It aims to see if treating both conditions together improves outcomes.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
This study tests a new medication called tirzepatide, given at carefully adjusted doses, to help people with obesity lose weight while reducing unwanted side effects. Tirzepatide is a newer injectable medicine that helps control appetite and blood sugar.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
Hear when a new Binge-Eating Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.